Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan.
Yen-Feng WangFu-Chi YangLu-An ChenTing-Yu ChangHui-Chen SuChun-Pai YangYi-Hsien TuYi-Shiang TzengShih-Pin ChenJong-Ling FuhKuan-Lin LaiYu-Hsiang LingWei-Ta ChenShuu-Jiun WangPublished in: European journal of neurology (2024)
In this multicenter, real-world study, CGRP mAbs were more effective than onabotulinumtoxinA in CM patients, even in DTT or MOH patients. All of these injectables were well tolerated. Further prospective studies are needed to verify these findings.